TFXNYSESEC EDGAREDGAR

TELEFLEX INC

Surgical & Medical Instruments & Apparatus·WAYNE, PA·FY end 12/31·CIK 96943

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$569.0M$3.0B$3.0B$2.8B$2.8B
Gross Profit$307.4M$1.7B$1.6B$1.5B$1.5B
Operating Income$13.9M$151.0M$506.3M$499.7M$628.1M
Net Income-$714.3M$69.7M$356.3M$363.1M$485.4M
Operating CF
Capex$95.2M$126.4M$91.4M$79.2M$71.6M
Free Cash Flow
Buybacks$300.0M$200.0M
Dividends$60.3M$63.5M$63.9M$63.8M$63.6M
Gross Margin54.0%55.9%55.4%54.9%55.2%
Operating Margin2.4%5.0%17.0%17.9%22.4%
Net Margin-125.5%2.3%12.0%13.0%17.3%
FCF Margin
R&D / Revenue25.4%5.3%5.2%5.5%4.7%
Effective Tax-138.4%7.0%17.6%18.6%13.3%
Debt / Equity1.660.750.800.830.96
Buybacks / FCF

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
TFX
131:1
BSX
348:1
SYK
264:1
MMM
316:1
PODD
213:1
BAX
257:1
CEO total comp
TFX
BSX
$24M
SYK
$21M
MMM
$21M
PODD
$19M
BAX
$18M
Net Margin
TFX
-125.5%
BSX
SYK
11.8%
MMM
13.0%
PODD
9.1%
BAX
-8.5%